The medical community is still learning about the long-term outcomes of GLP-1 usage for weight management, and what happens when the drugs are discontinued
Malaguarnera, M., Vacante, M., Giordano, M., Pennisi, G., Bella, R., Rampello, L., Malaguarnera, M., Li, Volti G., and Galvano, F
To view or add a comment, sign in Research presented by Marissa Shackleton at the National Infusion Center Association (NICA) 2026 Annual Conference compared oral diphenhydramine and dexamethasone IV (D-IV) and oral cetirizine and oral dexamethasone (C-PO) premedications for patients with multiple sclerosis (MS)
Additionally, IGF-1 LR3 is investigated for its interaction with insulin-like growth factor binding proteins (IGFBPs), which regulate peptide availability and receptor engagement
In other words, half the research is promising the other half makes you wonder if youre just becoming a very swole lab rat